AMRX vs MGM · P/E 44, rev $1.52B vs P/E 64, rev $4.45B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the AMRX and MGM stock pages for the full models.
Not investment advice.